financetom
Business
financetom
/
Business
/
BlackBerry Likely to Report Inline Fiscal Q1, Valuation to Remain Under Pressure, RBC Says
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
BlackBerry Likely to Report Inline Fiscal Q1, Valuation to Remain Under Pressure, RBC Says
Jun 21, 2024 10:14 AM

12:48 PM EDT, 06/21/2024 (MT Newswires) -- BlackBerry's (BB) is expected to report inline fiscal Q1 results, with revenue likely down 14% from a year earlier, RBC Capital Markets said in a note Friday.

The company is scheduled to release its quarterly results on June 26 after market close.

RBC projects Q1 revenue of $133 million, compared with consensus of $134 million and guidance of $130 million to $138 million. The forecast takes into account a patent sale last year, it said. The investment bank expects internet of things revenue to fall 25% sequentially to $50 million, in line with the company's guidance, and projects the decline to continue through fiscal 2025.

The brokerage expects a $0.05 loss per share on an adjusted basis for the quarter versus consensus of a $0.04 loss and guidance for a loss of $0.04 to $0.06. "BlackBerry's fiscal Q1 is likely to be a fairly noisy quarter given the company's ongoing restructuring, separation process, and headwinds against the business," RBC said.

It expects BlackBerry's valuation to remain under pressure until its "business stabilizes and the market gains confidence in a sustained move to profitability."

RBC is maintaining its sector perform rating for the company with a $3 price target.

Price: 2.37, Change: +0.05, Percent Change: +2.16

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Once a beacon of stability, Vietnam to name third president in a year
Once a beacon of stability, Vietnam to name third president in a year
Mar 22, 2024
HANOI, March 22 (Reuters) - Communist-ruled Vietnam is seeking its third president in little more than a year after the resignation of Vo Van Thuong, who was only elected last year after the sudden dismissal of his predecessor. With accumulated foreign direct investment higher than its gross domestic product, Vietnam's stability is crucial to multinationals with large operations in the...
Japan's union group Rengo announces biggest wage hikes on record
Japan's union group Rengo announces biggest wage hikes on record
Mar 22, 2024
TOKYO (Reuters) -Japanese firms have agreed to raise pay by 5.25% this year, the biggest rise under comparable data since 2013, the country's largest union group Rengo confirmed on Friday. The results of the closely-watched wage negotiations are announced in several stages, in which the blue-chip firms are first to wrap up their talks in mid-March. The second announcement on...
Cathie Wood's ARK Invest scoops up nearly 10,000 Reddit shares in debut
Cathie Wood's ARK Invest scoops up nearly 10,000 Reddit shares in debut
Mar 22, 2024
(Reuters) - Popular investor Cathie Wood's ARK Invest bought nearly 10,000 shares of Reddit ( RDDT ) in the social media platform's strong market debut on Thursday, an email from the asset manager showed. A total of 9,982 shares of the loss-making company was added to ARK Next Generation Internet ETF ( ARKW ) and ARK Fintech Innovation ETF (...
Hutchmed Begins Registration Stage for Phase 2/3 Trial of Investigational Autoimmune Disorder Drug
Hutchmed Begins Registration Stage for Phase 2/3 Trial of Investigational Autoimmune Disorder Drug
Mar 22, 2024
05:04 AM EDT, 03/22/2024 (MT Newswires) -- Hutchmed ( HCM ) said late Thursday it has started the registration stage for a phase 2/3 clinical trial of investigational drug sovleplenib for adult patients with warm antibody autoimmune hemolytic anemia in China. The move follows positive data from the proof-of-concept phase 2 stage of the trial and a consultation with the...
Copyright 2023-2026 - www.financetom.com All Rights Reserved